FDA.reportPublic FDA data

fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 60 Actuations

RxCUI
896239
RxNorm name
fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 60 Actuations
Display name
fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 60 Actuations
Full name
fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 60 Actuations
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADVAIR HFAFLUTICASONE PROPIONATE AND SALMETEROL XINAFOATEGlaxoSmithKline LLCdfaca6f9-3277-47b2-319d-1377917cb54c2024-05-23Warnings, Adverse reactionsExact identifier
rxcui: 896239

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dfaca6f9-3277-47b2-319d-1377917cb54cfluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 60 Actuations [PSN] · 60 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler [SCD] · fluticasone propionate 0.115 MG / salmeterol 0.021 MG per ACTUAT Metered Dose Inhaler, 60 ACTUAT [SY] · fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 60 ACTUAT [SY]437These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 200020240523